Renal cyclic AMP accumulation and adenulate cyclase stimulation by erythropoietic agents.
The regional distribution of cyclic AMP in the kidney was determined following erythropoietic stimulation with hypoxia and cobalt. Following these stimuli, increases in renal cyclic AMP concentrations were restricted to the cortex. The basis for this localization in the case of cobalt treatment was found to reside in the stimulation of renal cortical adenylate cyclase activity in vitro by concentrations of cobalt similar to those found in vivo. The level of cobalt in the cortex after cobalt treatment was found to approach 500 mumol/kg of tissue, whereas no detectable levels of cobalt were found in the renal medulla. Additionally, other agents such as parathyroid hormone and lactic acid, that are known to lack stimulatory effects on medullary adenylate cyclase, were found to stimulate the cortical enzyme. This stimulation of renal cortical adenylate cyclase correlates with enhanced erythropoiesis as demonstrated by increased radiolabeled iron incorporation into erythrocytes. These results support previous reports which suggest that renal cortical cyclic AMP mediates erythropoietin production in response to erythropoietically active agents.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D003035:Cobalt / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004920:Erythropoiesis / Q000187:drug effects; D005459:Fluorides / Q000494:pharmacology; D000860:Hypoxia / Q000378:metabolism; D007668:Kidney / Q000201:enzymology / Q000378:metabolism*; D007672:Kidney Cortex / Q000201:enzymology; D007679:Kidney Medulla / Q000201:enzymology; D007773:Lactates / Q000494:pharmacology; D010281:Parathyroid Hormone / Q000494:pharmacology; D051381:Rats
D007773:Lactates; D010281:Parathyroid Hormone; D003035:Cobalt; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D005459:Fluorides